Dr. Reddy's Laboratories
160 hedge funds and large institutions have $1.24B invested in Dr. Reddy's Laboratories in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 50 increasing their positions, 67 reducing their positions, and 30 closing their positions.
4.97% less ownership
Funds ownership: 84.71% → 79.73% (-5%)
8% less capital invested
Capital invested by funds: $1.34B → $1.24B (-$102M)
8% less funds holding
Funds holding: 174 → 160 (-14)
25% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 67
47% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 30
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
83% less call options, than puts
Call options by funds: $503K | Put options by funds: $2.99M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$55.9M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$12.1M |
| 3 |
GTP
Global Thematic Partners
New York
|
+$10.8M |
| 4 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
+$6.39M |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
+$6.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Principal Financial Group
Des Moines,
Iowa
|
-$16.3M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$15.3M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$11.7M |
| 4 |
D.E. Shaw & Co
New York
|
-$10.1M |
| 5 |
SCM
Segantii Capital Management
Hong Kong
|
-$9.36M |
RDY Hedge Fund Activity: Q1 2016 in Review
160 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2016, worth a combined $1.24B — down 7.6% from $1.34B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of RDY and 16 opened new positions — a net loss of 14 holders — while 67 trimmed existing stakes and 50 added.
The largest buyer was Royal Bank of Canada, adding an estimated $55.9M. The largest seller was Principal Financial Group, cutting an estimated $16.3M.
- 160 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2016, down from 174 in Q4 2015.
- Funds reported $1.24B of Dr. Reddy's Laboratories stock for Q1 2016, down 7.6% quarter-over-quarter.
- 16 funds opened new Dr. Reddy's Laboratories positions in Q1 2016 and 30 closed out, a net change of -14 holders.
- The largest Dr. Reddy's Laboratories buyer in Q1 2016 was Royal Bank of Canada, an estimated $55.9M added.
- The largest Dr. Reddy's Laboratories seller in Q1 2016 was Principal Financial Group, an estimated $16.3M sold.
Based on aggregated 13F filings for Q1 2016.